Echocardiographic findings following renal sympathetic denervation for treatment resistant hypertension, the ReShape CV-risk study

Anna Subbotinaa Department of Cardiology, University Hospital of North Norway, Tromsø, Norway;b Clinical Cardiovascular Research Group, UiT The Arctic University of Norway, Tromsø, NorwayCorrespondence[email protected]
View further author information

Eystein Skjølsvikc Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway;d Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, NorwayView further author information

Marit Dahl Solbue Section of Nephrology, University Hospital of North Norway, Tromsø, Norway;f Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, NorwayView further author information

Atena Miroslawskaa Department of Cardiology, University Hospital of North Norway, Tromsø, NorwayView further author information

Terje Steigena Department of Cardiology, University Hospital of North Norway, Tromsø, Norway;b Clinical Cardiovascular Research Group, UiT The Arctic University of Norway, Tromsø, NorwayView further author information

Echocardiographic findings following renal sympathetic denervation for treatment resistant hypertension, the ReShape CV-risk study

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Echocardiographic findings following renal sympathetic denervation for treatment resistant hypertension, the ReShape CV-risk study

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date